source
- Karyopharm Therapeutics to merge with Ayrmid as it enters bankruptcyKaryopharm Therapeutics, a commercial-stage biotech focused on blood cancers, announced it will pursue a merger with Ayrmid while navigating a bankruptcy process. The move aims to combine the two c…
- U.S. bioscience jobs up 7% from 2021 to 2025: ReportBioscience employment rose in 41 states, though not in California, according to a new report from the Biotechnology Innovation Organization and the Council of State Bioscience Associations.